Skin Diseases clinical trials
The registry lists 496 studies for Skin Diseases across more than 10 countries. 77 are recruiting or about to start. 153 of them are mainly about Skin Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 162 narrower conditions too, such as Breast Neoplasms: 35,254 studies, 7,215 open.
Get an email when these change. Save the Skin Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Status
Who runs them
TCI Co., Ltd. (27) · Novartis Pharmaceuticals (16) · Incyte Corporation (13) · Pfizer (11) · Eli Lilly and Company (11) · Amgen (9) · GlaxoSmithKline (7) · National Center for Research Resources (NCRR) (7)
What is being tested here
Drugs under test in Skin Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Lebrikizumab | 2 | 10 | 11 |
| IMG-007 | 2 | 0 | 4 |
| Tilrekimig | 2 | 2 | 2 |
| Ruxolitinib | 1 | 6 | 12 |
| Sonelokimab | 1 | 4 | 6 |
| Dupilumab | 1 | 1 | 3 |
| Baricitinib | 1 | 1 | 3 |
| Camoteskimab | 1 | 0 | 2 |
| Methoxsalen | 1 | 0 | 2 |
| Doxycycline | 1 | 0 | 1 |
Drug classes tested here Tyrosine kinase inhibitors (TKIs) 3 open · JAK inhibitors 2 open · Calcineurin inhibitors 4 · Corticosteroids 4 · Antimitotic agents 3
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest, phase 3 first
- Jan 2027Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp · Phase 3 · Sun Pharmaceutical Industries, Inc.
- Jan 2027Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities · Phase 3 · Sun Pharmaceutical Industries, Inc.
- Mar 2027Herbal Ointment in Treating Atopic Dermatitis Topically · Phase 3 · En Chu Kong Hospital
- Apr 2027A Study of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis · Phase 3 · Almirall, S.A.
- Nov 2026Cohesive Bandage Fixation of Pulse Oximeter Probes and Skin Condition in Preterm Neonates · Uskudar University
- Nov 2026A Study to Investigate Safety and Efficacy of KB111 for the Treatment of Hailey-Hailey Disease · Krystal Biotech, Inc.
- Nov 2026Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs · C5 Biomedical
- Dec 2026Observational Assessment of Skin Appearance Changes During PRX S Cosmetic Treatment in Participants With Acne-Prone Skin · WiQo S.p.A.
- Dec 2026Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa · Incyte Corporation
- Dec 2026Skin Reactions Related to Thoracic Implantable Chamber Dressings · Institut Curie
Who these studies take
Of the 55 Skin Diseases studies recruiting now, 27 (49%) set no upper age limit and 18 (33%) stop at 75 or younger. 20 (36%) take children under 18. 3 (5%) are for women only and 0 (0%) for men only; 20 (36%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 15 (27%) | 14 (25%) |
| 18 | 51 (93%) | 50 (91%) |
| 30 | 53 (96%) | 51 (93%) |
| 40 | 53 (96%) | 51 (93%) |
| 50 | 53 (96%) | 50 (91%) |
| 65 | 49 (89%) | 46 (84%) |
| 75 | 41 (75%) | 40 (73%) |
| 85 | 36 (65%) | 35 (64%) |
Across all 496 studies, recruiting or not: 34% stop at 75 or younger and 26% at 65; 26% take children; 6% are for women only and 2% for men only; 29% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Skin Diseases studies take
Of 60 phase 3 interventional studies under Skin Diseases, half reached primary completion within 19 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Phase 1 | 20 mo15–28 · 25 studies | — | — |
| Phase 2 | 15 mo10–28 · 57 studies | 13 mo10–19 · 42 studies | — |
| Phase 3 | 19 mo13–26 · 60 studies | 20 mo15–26 · 58 studies | — |
| Phase 4 | 24 mo16–45 · 13 studies | — | — |
| Interventional, no phase | 7 mo2–22 · 95 studies | 3 mo2–9 · 53 studies | 17 mo6–28 · 42 studies |
| Observational | 29 mo15–250 · 54 studies | — | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 13, 2026.
Started recruiting3
- A Study of HL40626S Tablets in Healthy AdultsOct 29, 2026NCT07736586
- A Study of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa (The SKYLIGHT Trial)Oct 19, 2026NCT07766005
- Driving Time and Facial Skin Hydration Asymmetry in Florida DriversOct 13, 2026NCT07764809
Results posted1
- The Impact of Chronic Adolescent Skin Conditions on Sexual HealthOct 26, 2026NCT06397664
Studies
Recruiting first, then most recently updated. Showing 50 of 496. Browse all 496 → or search them.
- Studies of Dermatologic Diseases Biospecimen Acquisition ProtocolRecruitingNCT024713521 country
- Effects of Treatments on Atopic DermatitisRecruitingNCT01631617Phase 21 country
- A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe EczemaRecruitingNCT07783425Phase 34 countries
- A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia AreataRecruitingNCT05723198Phase 312 countries
- Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper ExtremitiesRecruitingNCT07144852Phase 31 country
- Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and ScalpRecruitingNCT07144345Phase 31 country
- A Phase 1 Study of GTX-B001 in Healthy Subjects and Patients With Chronic Inducible UrticariaRecruitingNCT07181369Phase 11 country
- A Study of HL40626S Tablets in Healthy AdultsRecruitingNCT07736586Phase 11 country
- A Study of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa (The SKYLIGHT Trial)RecruitingNCT07766005Phase 22 countries
- A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe EczemaRecruitingNCT07765888Phase 32 countries
- OCT Vibrography for Biomechanical Properties of TissuesRecruitingNCT05759780Not applicable1 country
- Driving Time and Facial Skin Hydration Asymmetry in Florida DriversRecruitingNCT077648091 country
- Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis SuppurativaRecruitingNCT07049575Phase 11 country
- Phase 2 Trial of FT2109 for the Treatment of Psoriatic ArthritisNot yet recruitingNCT07869134Phase 2
- Observational Assessment of Skin Appearance Changes During PRX S Cosmetic Treatment in Participants With Acne-Prone SkinRecruitingNCT07866131Not applicable1 country
- Cohesive Bandage Fixation of Pulse Oximeter Probes and Skin Condition in Preterm NeonatesNot yet recruitingNCT07864298Not applicable1 country
- Extracorporeal Photopheresis in Early Diffuse Cutaneous Systemic SclerosisRecruitingNCT04986605Phase 21 country
- A Skin Image Reference Tool to Aid Healthcare Providers' DiagnosisRecruitingNCT070331691 country
- Public Attitudes Towards Traditional Medicine in Dermatological Care Within Blantyre, Malawi: Insights From Subject Matter ExpertsNot yet recruitingNCT07812844
- (Apex) Bezuclastinib in Patients With Advanced Systemic MastocytosisRecruitingNCT04996875Phase 214 countries
- Vitiligo Registry for Adults and Children in the UKNot yet recruitingNCT062180821 country
- Intertriginous/Periorificial Dermatoses in Patients With IBD on Anti-TNFα: Relative Abundance of Staphylococcus Aureus Within the Lesion Microbiota and Clinical Correlation (micSPIDER).Not yet recruitingNCT078126751 country
- An Observational Study of Patients With Dermatologic DiseaseNot yet recruitingNCT077481691 country
- Efficacy and Speed of Response of Lebrikizumab in High-Burden Prurigo Nodularis PatientsNot yet recruitingNCT07620561Phase 21 country
- A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic DermatitisRecruitingNCT07599813Phase 28 countries
- A Proof-of-Concept Study of LAD328 in Adults With Hidradenitis SuppurativaRecruitingNCT07547813Phase 21 country
- A Study of Lebrikizumab in Adults With Nummular EczemaRecruitingNCT07542483Phase 31 country
- A Phase II, Placebo Controlled, Clinical Trial of Topical TolaSure Targeting Aggregated Mutant Keratin in Epidermolysis Bullosa SimplexRecruitingNCT07027345Phase 21 country
- A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic DermatitisRecruitingNCT07037901Phase 24 countries
- A Study to Evaluate the Safety of BG-A3004 in Healthy Participants and Patients With Immune-Mediated Skin DiseasesRecruitingNCT07412691Phase 11 country
- Long-term Safety and Efficacy Evaluation of IMG-007 in Participants With Moderate-to-Severe Atopic DermatitisEnrolling by invitationNCT07734415Phase 22 countries
- A Study to Investigate Safety and Efficacy of KB111 for the Treatment of Hailey-Hailey DiseaseRecruitingNCT07717346Early Phase 11 country
- A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune DiseasesRecruitingNCT07115745Phase 110 countries
- A Synergistic Approach to Remodeling of Photodamaegd Skin: Exploring Laser-Assisted Biostimulator DeliveryNot yet recruitingNCT07680426Not applicable1 country
- Coping Strategies, Loneliness, and Resilience in Patients With DermatosisNot yet recruitingNCT07640373Not applicable1 country
- A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis SuppurativaEnrolling by invitationNCT07007637Phase 316 countries
- Biomedical Signal Extraction From Symptom Descriptions: An Observational Registry Using the OpenGenome PlatformRecruitingNCT075786101 country
- The Skin Microbiota in Skin Disease and EczemaEnrolling by invitationNCT069243331 country
- Repurposing Dupilumab for Management of Pruritic Genetic Inflammatory Skin DisordersRecruitingNCT05649098Early Phase 11 country
- Effectiveness of 0.9% Normal Saline Soaking in Managing Acute Radiation DermatitisNot yet recruitingNCT07553260Not applicable1 country
- Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic TargetRecruitingNCT008422831 country
- GMEB-SASS: A Gene-Modified Skin Substitute for RDEB TreatmentRecruitingNCT07193134Phase 1/21 country
- Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological DiseasesRecruitingNCT063876541 country
- Comparison of a Personalized Maintenance Therapy With the Standard Treatment in PemphigusRecruitingNCT05898308Phase 42 countries
- Efficacy Evaluation Study of Vitamin C and Glutathione Liquid SachetRecruitingNCT07379216Not applicable1 country
- Deep Phenotyping of CIndURecruitingNCT073594301 country
- Diagnosis Evaluation Made by Artificial Inteligence in Response to a Request Made by General Praticioner on OMNIDOC to the Dermatologist of the CHU of Nice. A Comparison of This Response by the One Made by the Dermatologist.Enrolling by invitationNCT073419061 country
- A Study to Learn About the Safety and Efficacy of the Drug Oleogel-S10 in Japanese Patients With Epidermolysis BullosaRecruitingNCT06917690Phase 31 country
- Optical Imaging Scans for the Diagnosis of Skin Cancer in Patients With LesionsRecruitingNCT07213154Not applicable1 country
- Global Managed Access Program Cohort for Remibrutinib in Adult Patients With Chronic Spontaneous UrticariaAvailableNCT05170724